OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Fighting Parkinson’s disease: The return of the mitochondria
Kevin Zambrano, Diego Barba, Karina Castillo, et al.
Mitochondrion (2022) Vol. 64, pp. 34-44
Closed Access | Times Cited: 31
Kevin Zambrano, Diego Barba, Karina Castillo, et al.
Mitochondrion (2022) Vol. 64, pp. 34-44
Closed Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
A Pivotal Role of Nrf2 in Neurodegenerative Disorders: A New Way for Therapeutic Strategies
Síbel Süzen, Paolo Tucci, Elisabetta Profumo, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 6, pp. 692-692
Open Access | Times Cited: 46
Síbel Süzen, Paolo Tucci, Elisabetta Profumo, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 6, pp. 692-692
Open Access | Times Cited: 46
A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease
Thomas Payne, Matthew Appleby, Ellen Buckley, et al.
Movement Disorders (2023) Vol. 38, Iss. 8, pp. 1493-1502
Open Access | Times Cited: 27
Thomas Payne, Matthew Appleby, Ellen Buckley, et al.
Movement Disorders (2023) Vol. 38, Iss. 8, pp. 1493-1502
Open Access | Times Cited: 27
Exploring the Prospective Role of Propolis in Modifying Aging Hallmarks
Carla A. Scorza, V Gonçalves, Josef Finsterer, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 390-390
Open Access | Times Cited: 9
Carla A. Scorza, V Gonçalves, Josef Finsterer, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 390-390
Open Access | Times Cited: 9
Ameliorating Mitochondrial Dysfunction for the Therapy of Parkinson's Disease
Qing Yin Zheng, Hanghang Liu, Yifan Gao, et al.
Small (2024) Vol. 20, Iss. 29
Closed Access | Times Cited: 8
Qing Yin Zheng, Hanghang Liu, Yifan Gao, et al.
Small (2024) Vol. 20, Iss. 29
Closed Access | Times Cited: 8
Mitochondria: At the crossroads between mechanobiology and cell metabolism
Émilie Su, Catherine Villard, Jean‐Baptiste Manneville
Biology of the Cell (2023) Vol. 115, Iss. 9
Open Access | Times Cited: 18
Émilie Su, Catherine Villard, Jean‐Baptiste Manneville
Biology of the Cell (2023) Vol. 115, Iss. 9
Open Access | Times Cited: 18
Mitochondrial Modulators: The Defender
Emmanuel Ayobami Makinde, Linlin Ma, George D. Mellick, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 226-226
Open Access | Times Cited: 17
Emmanuel Ayobami Makinde, Linlin Ma, George D. Mellick, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 226-226
Open Access | Times Cited: 17
Mitochondrial Toxicant-Induced Neuronal Apoptosis in Parkinson’s Disease: What We Know so Far
Narmadhaa Sivagurunathan, Priyadharshini Gnanasekaran, Calivarathan Latchoumycandane
Degenerative Neurological and Neuromuscular Disease (2023) Vol. Volume 13, pp. 1-13
Open Access | Times Cited: 16
Narmadhaa Sivagurunathan, Priyadharshini Gnanasekaran, Calivarathan Latchoumycandane
Degenerative Neurological and Neuromuscular Disease (2023) Vol. Volume 13, pp. 1-13
Open Access | Times Cited: 16
Inter-organellar Communication in Parkinson's and Alzheimer's Disease: Looking Beyond Endoplasmic Reticulum-Mitochondria Contact Sites
Stephanie Vrijsen, Céline Vrancx, Mara Del Vecchio, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 26
Stephanie Vrijsen, Céline Vrancx, Mara Del Vecchio, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 26
Mitochondrial membrane chromatography: Discovery of mitochondrial targeting modulators
Wu Su, Yu Kong, Hua Li, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101272-101272
Open Access
Wu Su, Yu Kong, Hua Li, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101272-101272
Open Access
Mitochondrial-based therapies for neurodegenerative diseases: a review of the current literature
Al-Hassan Soliman Wadan, Ahmed Shaaban, Mohamed El‐Sadek, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Al-Hassan Soliman Wadan, Ahmed Shaaban, Mohamed El‐Sadek, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Fingolimod exerts neuroprotection by regulating S1PR1 mediated BNIP3-PINK1-Parkin dependent mitophagy in rotenone induced mouse model of Parkinson's disease
Shruti Rajan, Anika Sood, Rachit Jain, et al.
Neuroscience Letters (2023) Vol. 820, pp. 137596-137596
Closed Access | Times Cited: 10
Shruti Rajan, Anika Sood, Rachit Jain, et al.
Neuroscience Letters (2023) Vol. 820, pp. 137596-137596
Closed Access | Times Cited: 10
Powering prescription: Mitochondria as “Living Drugs” – Definition, clinical applications, and industry advancements
Andrés Caicedo, Emilia Morales, Aldana Moyano, et al.
Pharmacological Research (2023) Vol. 199, pp. 107018-107018
Open Access | Times Cited: 8
Andrés Caicedo, Emilia Morales, Aldana Moyano, et al.
Pharmacological Research (2023) Vol. 199, pp. 107018-107018
Open Access | Times Cited: 8
A High-Throughput Screening of a Natural Products Library for Mitochondria Modulators
Emmanuel Ayobami Makinde, Linlin Ma, George D. Mellick, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 440-440
Open Access | Times Cited: 2
Emmanuel Ayobami Makinde, Linlin Ma, George D. Mellick, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 440-440
Open Access | Times Cited: 2
Progress in Mechanisms, Pathways and Cohort Studies About the Effects of PM2.5 Exposure on the Central Nervous System
Mengwen Ye, Jiacheng Yang, Jiaxin Li, et al.
Reviews of Environmental Contamination and Toxicology (2023) Vol. 261, Iss. 1
Closed Access | Times Cited: 6
Mengwen Ye, Jiacheng Yang, Jiaxin Li, et al.
Reviews of Environmental Contamination and Toxicology (2023) Vol. 261, Iss. 1
Closed Access | Times Cited: 6
Nanophytomedicines as Therapeutic Agents for Parkinson’s Disease
Jessica Burns, Amy Claire Buck, Sarah D’ Souza, et al.
ACS Omega (2023) Vol. 8, Iss. 45, pp. 42045-42061
Open Access | Times Cited: 6
Jessica Burns, Amy Claire Buck, Sarah D’ Souza, et al.
ACS Omega (2023) Vol. 8, Iss. 45, pp. 42045-42061
Open Access | Times Cited: 6
Role of cardiolipin in regulating and treating atherosclerotic cardiovascular diseases
Wei Jin, Meng Zhang, Xia Wang, et al.
European Journal of Pharmacology (2024) Vol. 979, pp. 176853-176853
Closed Access | Times Cited: 2
Wei Jin, Meng Zhang, Xia Wang, et al.
European Journal of Pharmacology (2024) Vol. 979, pp. 176853-176853
Closed Access | Times Cited: 2
Advancing mitochondria as a therapeutic agent
Andrés Caicedo, Keshav K. Singh
Mitochondrion (2023) Vol. 69, pp. 33-35
Closed Access | Times Cited: 6
Andrés Caicedo, Keshav K. Singh
Mitochondrion (2023) Vol. 69, pp. 33-35
Closed Access | Times Cited: 6
Evaluating Manganese, Zinc, and Copper Metal Toxicity on SH-SY5Y Cells in Establishing an Idiopathic Parkinson’s Disease Model
Sahar H. Pradhan, James Y. Liu, Christie M. Sayes
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16129-16129
Open Access | Times Cited: 5
Sahar H. Pradhan, James Y. Liu, Christie M. Sayes
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16129-16129
Open Access | Times Cited: 5
Non-Coding RNAs of Mitochondrial Origin: Roles in Cell Division and Implications in Cancer
Roberto Piergentili, Stefano Sechi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7498-7498
Open Access | Times Cited: 1
Roberto Piergentili, Stefano Sechi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7498-7498
Open Access | Times Cited: 1
Aging and mitochondrial transplantation
Mustafa Baran, Şevin Güney, Güler Öztürk, et al.
Elsevier eBooks (2024), pp. 475-492
Closed Access | Times Cited: 1
Mustafa Baran, Şevin Güney, Güler Öztürk, et al.
Elsevier eBooks (2024), pp. 475-492
Closed Access | Times Cited: 1
Understanding Post-COVID-19: Mechanisms, Neurological Complications, Current Treatments, and Emerging Therapies
Kevin Zambrano, Karina Castillo, Sebastian Peñaherrera, et al.
International Journal of General Medicine (2024) Vol. Volume 17, pp. 6303-6321
Open Access | Times Cited: 1
Kevin Zambrano, Karina Castillo, Sebastian Peñaherrera, et al.
International Journal of General Medicine (2024) Vol. Volume 17, pp. 6303-6321
Open Access | Times Cited: 1
A new hope: Mitochondria, a critical factor in the war against prions
Kevin Zambrano, Diego Barba, Karina Castillo, et al.
Mitochondrion (2022) Vol. 65, pp. 113-123
Closed Access | Times Cited: 6
Kevin Zambrano, Diego Barba, Karina Castillo, et al.
Mitochondrion (2022) Vol. 65, pp. 113-123
Closed Access | Times Cited: 6
Variable effects of omaveloxolone (RTA408) on primary fibroblasts with mitochondrial defects
Madleen Zighan, David Arkadir, Liza Douiev, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 6
Madleen Zighan, David Arkadir, Liza Douiev, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 6
Therapeutic potential of extracellular vesicles in Parkinson’s disease
Michelli Ramires Teixeira, Anderson Lucas Alievi, Vitor Rodrigues da Costa, et al.
Exploration of neuroscience (2023), pp. 106-122
Open Access | Times Cited: 3
Michelli Ramires Teixeira, Anderson Lucas Alievi, Vitor Rodrigues da Costa, et al.
Exploration of neuroscience (2023), pp. 106-122
Open Access | Times Cited: 3
Endonuclease VIII ‐like 1 deficiency potentiates nigrostriatal dopaminergic neuron degeneration in a male mouse model of Parkinson's disease
Yu‐Hsuan Chen, Yi‐Ying Kuo, Yi‐Qian You, et al.
Journal of Neurochemistry (2023) Vol. 165, Iss. 5, pp. 741-755
Closed Access | Times Cited: 2
Yu‐Hsuan Chen, Yi‐Ying Kuo, Yi‐Qian You, et al.
Journal of Neurochemistry (2023) Vol. 165, Iss. 5, pp. 741-755
Closed Access | Times Cited: 2
